| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.8B | $11.3B | $11.0B | $9.6B | $9.9B | $2.3B | $2.0B | $1.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.3B | $1.2B | $1.1B | $0.6B | $1.4B | $0.2B | $0.1B | $0.1B |
| Net Income | $0.9B | $0.9B | $0.8B | $0.4B | $1.0B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $2.52 | $2.34 | $1.99 | $1.05 | $2.34 | $0.36 | $0.24 | $0.19 |
| EPS (Diluted) | $2.51 | $2.33 | $1.97 | $1.04 | $2.28 | $0.35 | $0.23 | $0.19 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.8B | $11.1B | $12.0B | $11.8B | $13.2B | $10.9B | $7.0B | $4.6B |
| Current Assets | $2.4B | $2.7B | $3.4B | $3.9B | $4.7B | $4.9B | $2.3B | $2.0B |
| Cash & Equivalents | $0.5B | $0.7B | $1.1B | $1.1B | $1.1B | $1.2B | $1.0B | — |
| Total Liabilities | $4.7B | $4.7B | $4.9B | $4.7B | $5.3B | $4.4B | $3.8B | $1.6B |
| Current Liabilities | $2.2B | $2.3B | $2.4B | $2.2B | $2.4B | $2.1B | $1.7B | $1.3B |
| Stockholders' Equity | $5.4B | $5.7B | $6.4B | $6.5B | $7.1B | $6.2B | $3.1B | $2.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.4B | $1.5B | $1.4B | $1.1B | $1.1B | $1.2B | $1.3B |
| Investing Cash Flow | $-0.0B | $-0.2B | $-0.7B | $-0.5B | $-0.9B | $-3.1B | $-0.9B | $-0.6B |
| Capital Expenditures | $0.6B | $0.7B | $0.7B | $0.7B | $0.7B | $0.4B | $0.4B | $0.5B |
| Financing Cash Flow | $-1.7B | $-1.6B | $-0.7B | $-0.8B | $-0.3B | $2.1B | $-0.5B | $-0.5B |